Use of Fluorescein Isothiocyanate Isomer I to Study the Mechanism of Intestinal Absorption of Fucoidan Sulfate in Vivo and in Vitro

E. Zhang,Fulong Chu,Lixu Xu,Hao Liang,Shuliang Song,Aiguo Ji
DOI: https://doi.org/10.1002/bdd.2137
2018-01-01
Biopharmaceutics & Drug Disposition
Abstract:A new method to label fucoidan sulfate was established with tyramine and fluorescein isothiocyanate isomer I (FITC). Fluorescence spectrophotometry and high performance liquid chromatography verified the successful labelling of fucoidan by FITC. The results of the single-pass intestinal perfusion indicated that the jejunum and ileum are the main absorption sites, and there was carrier saturation. In addition, fucoidan sulfate at 1 mg/ml had no inhibitory effect on Caco-2 cell proliferation. Studies on the transmembrane transport mechanism showed that fucoidan can be absorbed because the apparent permeability coefficient of the drugs (P-app) A -> B was 3.78+0.03 x 10(-6) and that of B -> A was 1.42+0.19 x 10(-6). The peak absorption of fucoidan occurred at 120 min after administration; moreover, the higher the concentration used, the worse the absorption was, suggesting the saturation of transport carriers. The absorption was temperature dependent: the absorption at 37 degrees C was much better than that at 4 degrees C. Further, the absorption of fucoidan sulfate might rely on clathrin endocytosis as chlorpromazine (10 mu g/ml) significantly inhibited it.
What problem does this paper attempt to address?